Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma

登录注册会员服务联系我们

Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma—Reply

Published:2018-08-01 Issue:8 Volume:4 Page:1136
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Sinnamon Andrew J.¹²,Gimotty Phyllis A.²,Karakousis Giorgos C.¹

Affiliation:

1. Department of Surgery, Oncologic Surgery, Hospital of the University of Pennsylvania, Philadelphia

2. Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference6 articles.

1. Association of first-in-class immune checkpoint inhibition and targeted therapy with survival in patients with stage IV melanoma.;Sinnamon;JAMA Oncol,2018

2. strmst2 and strmst2pw: new commands to compare survival curves using the restricted mean survival time.;Cronin;Stata J,2016

3. Improved survival with ipilimumab in patients with metastatic melanoma.;Hodi;N Engl J Med,2010

4. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.;Robert;N Engl J Med,2011

5. Improved survival with vemurafenib in melanoma with BRAF V600E mutation.;Chapman;N Engl J Med,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis?;Journal of Clinical Oncology;2019-12-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP